Thoracic Anatomy
Lung Lobes
  • Right lung (3 lobes): Upper (RUL), Middle (RML), Lower (RLL) — separated by oblique and horizontal fissures
  • Left lung (2 lobes): Upper (LUL) and Lower (LLL) — separated by oblique fissure only
  • Lingula: Tongue-like projection of LUL; functionally equivalent to right middle lobe
  • Right lung: Slightly larger; receives ~55% of cardiac output
  • Bronchopulmonary segments: 10 right / 8–10 left — each with independent bronchus and vasculature
Bronchial Tree & Pleural Space
  • Trachea bifurcates at carina (T4/T5) → right and left main bronchi
  • Right main bronchus: Shorter, wider, more vertical — aspirated foreign bodies lodge more easily on right
  • Pleural space: Potential space between visceral and parietal pleura; normally contains 5–15 mL serous fluid
  • Visceral pleura: Covers lung surface; no pain fibres
  • Parietal pleura: Lines chest wall; pain sensitive (intercostal/phrenic nerves)
Mediastinum Compartments
CompartmentContentsCommon Pathology
AnteriorThymus, fat, lymph nodesThymoma, teratoma, lymphoma (thyroid goitre extending)
MiddleHeart, pericardium, ascending aorta, SVC/IVC, trachea, main bronchi, phrenic nervesPericardial/bronchogenic cysts, lymphoma
PosteriorOesophagus, descending aorta, thoracic duct, sympathetic chain, vagus nervesNeurogenic tumours, oesophageal pathology
Lung Cancer
Epidemiology: Most common cause of cancer death worldwide. Smoking accounts for ~85% of cases. In GCC, high prevalence among males due to elevated smoking rates.
NSCLC — 85% of Lung Cancers
  • Adenocarcinoma (~40%): Peripheral, most common in non-smokers/women; EGFR/ALK mutations relevant for targeted therapy
  • Squamous cell (~25%): Central, associated with smoking; cavitation common; hypercalcaemia (PTHrP)
  • Large cell (~10%): Peripheral, undifferentiated, poor prognosis
  • Staging: TNM system — T (tumour size/invasion), N (nodal involvement), M (metastasis)
  • Resectable: Stage I–IIIA depending on N-status and mediastinal involvement
SCLC — 15% of Lung Cancers
  • Neuroendocrine origin; small oat-shaped cells
  • Strongly associated with smoking
  • Central location, early metastasis
  • Limited disease: Confined to one hemithorax — chemoradiotherapy
  • Extensive disease: Beyond one hemithorax — chemotherapy alone
  • Surgery rarely indicated (very early limited disease only)
  • Paraneoplastic syndromes: SIADH, Cushing's, Lambert-Eaton myasthenic syndrome
Resectability Criteria — Pulmonary Function Thresholds
ParameterAcceptable ThresholdHigh Risk
Predicted post-op FEV1 (ppoFEV1)>40% predicted<30% — very high risk
Predicted post-op DLCO (ppoDLCO)>40% predicted<30% — very high risk
VO2 max (CPET)>15 mL/kg/min safe; 10–15 borderline<10 mL/kg/min — prohibitive risk
6-minute walk test>400 m — good functional capacity<400 m — consider CPET
Formula: ppoFEV1 = preoperative FEV1 × (1 − fraction of functional lung to be removed). Segment counting method: divide by total functional segments (19 right / 19 left approach varies by institution).
Pleural Conditions
Pneumothorax
  • Primary spontaneous: No underlying lung disease; tall young males; subpleural blebs
  • Secondary spontaneous: Underlying lung disease (COPD, CF, asthma); more dangerous — less respiratory reserve
  • Traumatic: Penetrating/blunt trauma; may cause haemopneumothorax
  • Iatrogenic: Post-procedure (CVC insertion, thoracocentesis, lung biopsy)
  • Tension pneumothorax: One-way valve — progressive air accumulation; tracheal deviation away, absent breath sounds, hypotension — clinical emergency: immediate needle decompression 2nd ICS MCL
Pleural Effusion — Light's Criteria

Differentiate transudate from exudate using Light's criteria (all 3 criteria must be absent for transudate):

Exudate if ANY of: Pleural protein/serum protein >0.5 | Pleural LDH/serum LDH >0.6 | Pleural LDH >2/3 upper limit of normal serum LDH
  • Transudates: Heart failure (bilateral), hypoalbuminaemia, cirrhosis, nephrotic syndrome, hypothyroidism
  • Exudates: Pneumonia (parapneumonic), malignancy, TB, pulmonary embolism, rheumatoid
Empyema
  • Infected pleural fluid (frank pus or organisms on microscopy)
  • Stages: Exudative → Fibrinopurulent → Organised (fibrous peel)
  • Causative organisms: Streptococcus milleri, Staphylococcus aureus, anaerobes, gram-negatives
  • Management: Chest drain + IV antibiotics (early); surgical decortication (organised stage)
  • Intrapleural fibrinolytics (tPA + DNase) for complex loculated effusions
Mesothelioma
  • Malignant pleural mesothelioma — linked to asbestos exposure (latency 30–50 years)
  • GCC relevance: Historical construction industry asbestos use; expat workers at risk
  • Features: Pleural thickening (circumferential), haemorrhagic effusion, chest pain, dyspnoea
  • Types: Epithelioid (best prognosis), sarcomatoid (worst), biphasic
  • Prognosis: Median survival 12–18 months; palliative management predominant
  • Multimodal treatment: Pleurectomy/decortication or EPP in selected patients
Other Thoracic Conditions
Bronchiectasis
  • Permanent dilatation of bronchi from chronic inflammation/infection
  • Chronic productive cough (copious purulent sputum)
  • Causes: post-infective (TB, whooping cough), CF, immunodeficiency
  • Pseudomonas aeruginosa colonisation in established disease
  • Complications: Haemoptysis, respiratory failure, cor pulmonale
  • Management: Airway clearance physiotherapy, antibiotics, surgery (localised disease)
Tracheal Conditions
  • Tracheal stenosis: Subglottic/tracheal narrowing — post-intubation (ischaemic injury from cuff), post-tracheostomy, or idiopathic; presents with stridor, dyspnoea
  • Tracheomalacia: Weakened/collapsible tracheal cartilage; dynamic collapse on expiration; exertional dyspnoea, brassy cough
  • Management: Dilation, stenting, tracheal resection and reconstruction
Mediastinal Tumours — 4T's
  • Thymoma: Anterior; associated with myasthenia gravis (~30% cases)
  • Teratoma/Germ cell: Anterior; AFP/β-hCG markers; benign (mature) vs malignant
  • Terrible lymphoma: Anterior or middle; Hodgkin's or NHL; fever, night sweats, weight loss (B symptoms)
  • Thyroid (goitre): Can extend retrosternally causing tracheal compression
  • Neurogenic tumours: Posterior mediastinum; schwannoma, neurofibroma
Indications & Drain Types
Indications for Chest Drain
  • Pneumothorax (large/symptomatic/secondary spontaneous/tension after decompression)
  • Haemothorax — blood in pleural space
  • Pleural effusion — symptomatic or requiring sampling
  • Empyema — infected pleural fluid
  • Post-thoracic surgery (routine drain post-lobectomy/pneumonectomy)
  • Chylothorax — lymphatic fluid leak
Drain Types
TypeSizeIndication
Seldinger (small bore)10–14 FrEffusion, pneumothorax (non-surgical)
Surgical (large bore)24–32 FrHaemothorax, empyema, post-surgical
  • Seldinger technique: Guide wire + dilators — less painful, suitable for bedside under USS
  • Surgical insertion: Blunt dissection through intercostal space — more reliable for viscous fluid
Triangle of Safety — Insertion Site
Anatomical Boundaries
  • Anterior border: Lateral border of pectoralis major
  • Posterior border: Lateral border of latissimus dorsi
  • Inferior border: 5th intercostal space (level of nipple in males)
  • Superior border: Base of axilla
Insertion rule: Needle/drain inserted OVER the superior border of the rib below to avoid the neurovascular bundle (vein, artery, nerve run in subcostal groove — VAN from top to bottom).
Water Seal Drainage
Understanding the Underwater Seal

The underwater seal acts as a one-way valve — air can exit the pleural space but cannot re-enter. The drain tubing is submerged 2 cm below the water surface.

Swinging (tidalling): Fluid in the drain tube rises on inspiration and falls on expiration (or opposite in mechanically ventilated patients). Indicates the drain is PATENT and in the pleural space.
Bubbling through the water seal: Indicates an ongoing air leak from the lung (e.g., alveolar-pleural fistula post-resection). Bubbling should reduce and cease as lung heals. Continuous vigorous bubbling = large air leak.
Absence of swinging: May indicate drain blockage (kinking/clot) or full lung re-expansion (desired outcome).
ObservationInterpretation
Swinging + no bubblingPatent drain, lung expanding, no air leak
Swinging + bubblingPatent drain with active air leak
No swinging + no bubblingBlocked drain OR lung fully expanded
No swinging + bubblingPossible disconnection or system leak
Fluid output >200 mL/hHaemothorax/haemorrhage — urgent review
NEVER clamp a bubbling drain — risk of tension pneumothorax.
Drainage Systems
  • Traditional 3-bottle system: Bottle 1 (collection) → Bottle 2 (water seal) → Bottle 3 (suction control)
  • Atrium/Pleurevac (integrated system): Single unit with collection chamber, water seal chamber, and suction control chamber — most common in clinical practice
  • Suction: -10 to -20 cmH₂O applied to aid drainage; indicated for large air leaks or poor re-expansion
  • Heimlich flutter valve: Portable one-way valve for ambulatory management of pneumothorax
Clamping — Strict Indications Only
  • During transport (brief, attended, patient stable)
  • Controlled drainage of large effusion (>1.5 L total — clamp after 1 L to prevent re-expansion pulmonary oedema)
  • When changing drainage system (momentary)
  • Assessing if drain ready for removal (trial clamping period under monitoring)
NEVER clamp: Active air leak/bubbling | Respiratory distress | Post-pneumonectomy drainage
Nursing Observations & Complications
Comprehensive Chest Drain Nursing Assessment

Routine Observations (Hourly)

  • Drain output: Volume, colour (serous/serosanguinous/haemorrhagic/purulent), consistency
  • Swinging assessment — patient breathing spontaneously
  • Bubbling — continuous, intermittent or absent
  • Water seal level — maintain 2 cm below surface
  • Tubing — no kinks, dependent loops, or clots
  • Drain entry site — dressing integrity, signs of infection or subcutaneous emphysema
  • Patient position — 30–45° semi-recumbent promotes drainage
  • SpO₂, respiratory rate, breath sounds

Complications & Actions

  • Blocked drain: Absent swinging, no drainage — gentle milking/stripping (gloves on); DO NOT forcefully strip
  • Drain displacement: Partially out — do NOT reinsert; cover with occlusive dressing, notify team
  • Subcutaneous emphysema: Crackling sensation on palpation around insertion site; common, usually self-limiting; monitor for spread
  • Surgical emphysema: Extensive subcutaneous air — can extend to neck/face; may require additional drain or drain repositioning
  • Haemorrhage: >200 mL/h for 2 consecutive hours — urgent surgical review
  • Re-expansion pulmonary oedema: After rapid large-volume drainage — SpO₂ drop, cough, pink frothy sputum
Chest Drain Removal
Pulmonary Function Assessment
Spirometry & Lung Function Tests
TestParameterSignificance
SpirometryFEV₁/FVC ratio<70% = obstructive pattern (COPD, asthma); >70% with reduced FVC = restrictive
FEV₁ % predicted% of expectedPredicts post-op respiratory reserve; >80% normal
DLCODiffusion capacity for COReflects gas exchange capacity; reduced in emphysema, interstitial disease
6-minute walk testDistance walked (m)>400 m = adequate; <400 m = refer for CPET
Shuttle walk testLevels achievedIncremental, externally paced; good surgical risk predictor
CPET (VO₂ max)mL O₂/kg/minGold standard; >20 = low risk; 10–15 = borderline; <10 = very high risk
Clinical Pearl: CPET is the gold standard for surgical risk assessment in borderline candidates. It assesses the entire oxygen transport chain under exercise stress — cardiac, pulmonary, and muscular function simultaneously.
Prehabilitation
Smoking Cessation
  • Cessation at least 4 weeks before surgery to allow mucociliary clearance recovery
  • Benefits: Reduced airway secretions, improved ciliary function, reduced carbon monoxide levels (improves tissue oxygenation within 24 hours)
  • GCC context: High smoking prevalence in GCC males — critical component of nursing education
  • Cessation aids: Nicotine replacement therapy (NRT), varenicline (Champix), behavioural support
  • Earlier cessation (>8 weeks) reduces pulmonary complication risk significantly
Physiotherapy & Exercise Prehabilitation
  • Inspiratory muscle training (IMT): Threshold loading devices — strengthens diaphragm and inspiratory muscles
  • Aerobic exercise programme: Supervised walking/cycling programme; aim to increase VO₂ max by ≥2 mL/kg/min pre-op
  • Airway clearance techniques: Active cycle of breathing (ACBT), autogenic drainage
  • Upper limb exercises: Important for post-thoracotomy recovery
  • Duration: Minimum 4 weeks; 6–8 weeks preferred for high-risk patients
Pre-operative Nursing Assessment & Preparation
Nutritional Optimisation
  • MUST (Malnutrition Universal Screening Tool) — score 0 (low), 1 (medium), ≥2 (high risk)
  • Malnutrition → increased infection risk, impaired wound healing, prolonged ICU stay
  • Oral nutritional supplements (ONS) if MUST score ≥2 or BMI <18.5
  • Pre-operative fasting: 6 hours for solid food; 2 hours for clear fluids (ERAS protocol)
  • Carbohydrate loading drinks (e.g., Preload) — up to 2 hours pre-op reduces insulin resistance
DVT Prophylaxis
  • Mechanical: TED (anti-embolism) stockings — measure and fit correctly; contraindicated in peripheral arterial disease
  • Pharmacological: Low molecular weight heparin (LMWH) — e.g., enoxaparin 40 mg SC once daily (dose-adjusted for weight/renal function)
  • Start LMWH: Usually 12 hours pre-op or immediate post-op
  • Pneumatic compression devices (PCD) during surgery
  • Early mobilisation — post-op day 1 target
Anaesthetic Review & Regional Analgesia Planning
  • Thoracic epidural: T4–T6 level; superior pain control post-thoracotomy; reduces respiratory complications; requires specialist placement and monitoring
  • Paravertebral block (PVB): Unilateral somatic block; fewer haemodynamic side effects than epidural; can be single-shot or catheter-based
  • Serratus anterior plane block: Emerging technique for VATS analgesia
  • Regional anaesthesia superior to opioid-only regimens for pulmonary outcomes
  • One-lung ventilation (OLV): Double-lumen endotracheal tube (DLT) or bronchial blocker — allows surgical access while contralateral lung ventilated
  • Lateral decubitus position — standard for thoracotomy
  • Lung isolation complications: Hypoxaemia during OLV (HPV optimised by low FiO₂ avoidance)
  • Consider epidural test dose: 3 mL 1.5% lidocaine with adrenaline — checks for intravascular/intrathecal placement
Pre-operative Investigations & Consent

Investigations Checklist

  • Blood tests: FBC, U&E, LFTs, coagulation, group & crossmatch, ABG
  • Spirometry + DLCO (± CPET)
  • CXR (PA and lateral)
  • CT thorax with contrast (staging)
  • PET-CT scan — metabolic activity, distant metastases
  • EBUS/mediastinoscopy — nodal staging
  • Echocardiogram if cardiac risk factors

Consent — Risks to Discuss

  • Haemorrhage (intra-/post-operative)
  • Prolonged air leak (>7 days — may require further intervention)
  • Wound infection / empyema
  • Respiratory failure / need for prolonged ventilation
  • Pneumonia
  • Atrial fibrillation (10–40% post-thoracotomy)
  • Cardiac complications (MI, arrhythmia)
  • Bronchopleural fistula (rare but serious)
  • Death (procedure-specific mortality: lobectomy ~1–2%, pneumonectomy ~3–6%)
Pain Management
Multimodal Analgesia — Thoracic Epidural (Gold Standard)
  • Thoracic epidural: Local anaesthetic ± opioid infusion (e.g., bupivacaine 0.125% + fentanyl 2 mcg/mL)
  • Assess dermatomal level hourly — target T3–T8 for thoracotomy
  • Monitor for hypotension — epidural sympathetic blockade reduces afterload; treat with IV fluids or vasopressors as per protocol
  • Assess motor block — Bromage scale; dense leg block requires dose reduction
  • Check for urinary retention (indwelling catheter usually in situ)
  • Headache — if positional (worse upright) consider post-dural puncture headache
  • Paravertebral block: Catheter-based infusion; unilateral; fewer hypotensive episodes; increasingly preferred in VATS
  • Regular paracetamol: 1 g QDS — baseline analgesia; reduces opioid requirements
  • NSAIDs: Ibuprofen/diclofenac if no contraindication (renal function, GI history, post-pneumonectomy caution)
  • PCA (patient-controlled analgesia): Morphine or oxycodone — if regional analgesia fails or not in situ
  • Opioid side effects monitoring: Sedation score, respiratory rate ≥8/min, PONV
Pain management is critical in thoracic surgery: Inadequate analgesia → splinting → reduced cough → sputum retention → pneumonia → respiratory failure. Prioritise effective analgesia to enable deep breathing and physiotherapy.
Post-operative Chest Drain Management
Post-surgical Drain Monitoring — Critical Thresholds
FindingActionUrgency
Output >200 mL/h for 2 consecutive hoursNotify surgical team — suspect haemorrhage; prepare for return to theatreURGENT
Sudden cessation of drainage + haemodynamic instabilitySuspect clotted haemothorax; do NOT clamp; notify teamURGENT
Continuous bubbling not improving by post-op day 3Notify surgical team — consider bronchoscopy/re-operationREVIEW
Output milky/chylous (white)Suspect chylothorax (thoracic duct injury) — nil fat diet, nutritional supportREVIEW
Drain criteria met (no leak + <150 mL/24h)Prepare for removal per protocolROUTINE
Respiratory Care
Respiratory Monitoring & Physiotherapy
  • High-dependency monitoring: SpO₂ continuous, RR hourly, ETCO₂ if intubated, ABG as indicated
  • Incentive spirometry: 10 breaths every hour while awake — target pre-op FEV₁ volume; reduces atelectasis
  • Flutter valve/Acapella: Oscillating positive expiratory pressure — mobilises secretions
  • Active cycle of breathing (ACBT): Breathing control → thoracic expansion → forced expiration technique (huff)
  • Early mobilisation: Sit out of bed within 6–12 hours post-op; walk day 1 (supported)
  • Supplemental oxygen: Target SpO₂ 94–98% (88–92% if known type 2 respiratory failure risk)
  • Positioning: 30–45° head-up at all times
Fluid Management Post-thoracotomy
  • Restrictive fluid strategy: Avoid fluid overload — remaining lung vulnerable to hydrostatic oedema
  • Target: Zero to slightly negative fluid balance in first 24–48 hours
  • Monitor: Urine output (≥0.5 mL/kg/h), CVP (if monitored), daily weights
  • Post-pneumonectomy: STRICT fluid restriction — max 1 L/day; fluid overload = fatal pulmonary oedema in remaining lung
  • Post-pneumonectomy pulmonary oedema: mortality 50–100% — do NOT give unnecessary IV fluids
Atrial Fibrillation Post-thoracotomy
AF Post-thoracotomy — Common Complication
  • Incidence: 10–40% of patients post-thoracotomy; higher after pneumonectomy
  • Onset: Usually post-op day 2–4 (peak around day 2)
  • Mechanism: Autonomic nervous system disruption, inflammation, atrial stretch, electrolyte disturbance
  • Risk factors: Age >60, pre-existing cardiac disease, electrolyte abnormalities, right-sided resection, pneumonectomy
  • Management options:
  • Haemodynamically stable: Rate control — metoprolol or diltiazem; amiodarone if LV dysfunction
  • Haemodynamically unstable: Synchronised DC cardioversion
  • Anticoagulation: If AF >48 hours or unknown duration — LMWH/warfarin/DOAC per cardiology
  • Correct electrolytes: Potassium >4.0 mmol/L; magnesium sulphate 10 mmol IV (rate-limiting)
  • Most convert to sinus rhythm within 6 weeks
Nursing Action: 12-lead ECG for any new irregular rhythm; monitor blood pressure (AF can cause haemodynamic instability); notify medical team; continuous cardiac monitoring; prepare for cardioversion if patient deteriorates.
Pneumonectomy — Specific Nursing Care
Pneumonectomy Nursing — Critical Points
Pneumonectomy = removal of an entire lung. The pneumonectomy space gradually fills with fluid over 3–6 months. CXR will show progressive mediastinal shift towards the operative side — this is NORMAL and expected.
  • Chest drain: NOT routinely used; if placed, it is balanced (not connected to suction) — prevents mediastinal shift from pressure differential
  • NEVER manipulate the drain vigorously post-pneumonectomy
  • Cardiac shift risk: Excessive shift can cause cardiac herniation — life-threatening; maintain careful positioning
  • Fluid restriction: Maximum 1 L IV fluid in first 24 hours
  • Post-pneumonectomy pulmonary oedema: Rare (2–4%) but 50%+ mortality
  • Bronchopleural fistula: Rare (1–5%); bronchial stump dehiscence; presents as sudden haemoptysis, subcutaneous emphysema, haemodynamic deterioration
  • CXR changes: Air-fluid level in pneumonectomy space; mediastinal shift AWAY from operative side = cardiac herniation risk
  • Position: Operative side DOWN if ordered (prevents flooding remaining lung if fistula)
  • Cardiac arrhythmias: Higher risk post-pneumonectomy — continuous monitoring ×72 hours minimum
VATS vs Open Thoracotomy
VATS — Video-Assisted Thoracoscopic Surgery
FeatureVATSOpen Thoracotomy
Incisions3 small ports (5–15 mm)Single large posterolateral incision (20–25 cm)
Rib spreadingNot requiredRib spreader (major source of pain)
Pain levelSignificantly lessSevere — major nerve injury risk
Hospital stay2–4 days5–7+ days
Recovery time2–4 weeks6–8 weeks
Pulmonary complicationsLower incidenceHigher incidence
Blood lossReducedGreater
Oncological outcomesEquivalent to open for stage I–II NSCLCStandard for complex resections
RATS (Robotic-assisted thoracic surgery): Enhanced 3D visualisation and instrument articulation; emerging technology; similar outcomes to VATS with potential for more complex resections; longer operating times; higher equipment cost.
Pleurodesis Nursing Care
Pleurodesis — Mechanism & Nursing
  • Purpose: Obliterate pleural space to prevent recurrence of effusion or pneumothorax
  • Indications: Recurrent malignant pleural effusion; recurrent pneumothorax (especially secondary spontaneous)
  • Agents: Talc (most effective), bleomycin, doxycycline, iodopovidone
  • Talc delivery: Talc slurry via chest drain OR talc poudrage (surgical insufflation during VATS)
  • Pre-procedure: Ensure lung fully expanded; adequate analgesia; written consent

Post-Pleurodesis Nursing Care

  • Pain: Severe pleuritic pain 2–4 hours post-talc — CRITICAL to pre-empt with analgesia (regular paracetamol + NSAIDs + strong opioid PRN)
  • Systemic inflammatory response: Fever (38–39°C), tachycardia — self-limiting; reassure patient; not infectious
  • Drain rotation: Change patient position (supine, each lateral, prone if tolerated) every 15–30 minutes for 2 hours to distribute talc
  • Monitor: SpO₂, CXR post-procedure, drain output
  • Drain removal: Usually 24–48 hours post-procedure if drainage <150 mL/24h
Bronchoscopy
Bronchoscopy Types & Nursing Role
TypePurposeNursing Role
FlexibleDiagnostic (BAL, brushings, biopsy), assessment of airways, therapeutic (secretion clearance)Conscious sedation monitoring (midazolam/alfentanil), SpO₂ & BP monitoring, topical anaesthesia (lidocaine), post-procedure NPO ×1 hour (until gag reflex returns)
RigidForeign body removal, massive haemoptysis control, stent insertion, large airway tumoursGeneral anaesthesia care, jet ventilation monitoring, airway equipment preparation (suction, bronchoscopes, stents)
EBUSEndobronchial ultrasound — mediastinal lymph node sampling for staging; TBNA (transbronchial needle aspiration)Same as flexible; longer procedure time; assist with specimen labelling and transport to cytology
Post-flexible bronchoscopy: Nil by mouth for 1 hour (until gag reflex returns); monitor for haemoptysis, pneumothorax (if biopsy performed — post-procedure CXR); temperature monitoring for 4 hours (infection risk).
Pleural Aspiration (Thoracocentesis)
Thoracocentesis — Diagnostic vs Therapeutic
  • Diagnostic aspiration: 50 mL — send for protein, LDH, pH, glucose, cytology, MC&S, AFB (if TB suspected)
  • Therapeutic aspiration: Maximum 1 litre at a single sitting — prevent re-expansion pulmonary oedema
  • If patient develops chest tightness/cough/SpO₂ drop mid-procedure — STOP immediately
  • Ultrasound guidance: Standard of care — reduces complication rate significantly
  • Pre-procedure nursing: Consent, USS confirmation of fluid, patient positioning (sitting upright/leaning forward), baseline obs
  • Complications to monitor: Pneumothorax (post-procedure CXR), vasovagal response (bradycardia/hypotension), haemothorax, re-expansion pulmonary oedema
  • Post-procedure: CXR, obs ×4 hours, document fluid appearance and volume
Re-expansion pulmonary oedema: Occurs when large volume drained rapidly (>1 L) or chronically collapsed lung expands suddenly. Signs: severe cough, SpO₂ drop, pink frothy sputum. Treat with high-flow oxygen, sit upright, consider NIV. Prevention: limit drainage to 1 L per session.
Other Thoracic Procedures
Medical Thoracoscopy
  • Single-port procedure under conscious sedation (local anaesthesia)
  • Performed by respiratory physicians (vs VATS by surgeons)
  • Indications: Undiagnosed exudative effusion, pleural biopsy, talc pleurodesis
  • Post-procedure: Chest drain in situ for 24–48 hours, CXR, standard drain nursing
  • Diagnostic yield: Superior to pleural aspiration alone (~90% vs ~60% for malignancy)
Intercostal Nerve Block
  • Local anaesthetic (bupivacaine 0.5%) injected around intercostal nerve
  • Provides unilateral somatic analgesia for 6–12 hours
  • Often used intraoperatively under direct vision or post-procedurally for chest drain site pain
  • Nursing: Monitor for systemic LA toxicity (LAST) — metallic taste, tinnitus, seizures, cardiac arrhythmias
  • Intralipid 20% must be available when high-dose LA used (LAST rescue)
GCC Regional Context
GCC-Specific Thoracic Epidemiology
  • Lung cancer in GCC males: Elevated rates driven by high smoking prevalence (30–40% in some GCC countries); shisha/hookah also a risk factor (equivalent tobacco exposure)
  • Mesothelioma: Historical construction booms used asbestos-containing materials; latency 30–50 years means cases now presenting; particularly relevant in UAE, Qatar, Kuwait construction heritage
  • TB-related pleural effusions: Significant among South Asian and African expat workers; exudative effusion + ADA elevation + lymphocytic predominance = TB until proven otherwise
  • COPD prevalence: Underdiagnosed in GCC; major co-morbidity in thoracic surgical patients
GCC Licensing Exam Focus Areas
  • DHA (Dubai Health Authority): Emphasis on evidence-based nursing care, post-op monitoring, patient safety
  • DOH (Abu Dhabi Department of Health): Clinical competency, medication management, infection control
  • SCFHS (Saudi Commission for Health Specialties): Saudi Prometric nursing licensing; comprehensive clinical knowledge
  • Key thoracic topics tested: Chest drain management, post-thoracotomy AF, pneumothorax management, pulmonary function interpretation, pleurodesis nursing
  • Priority assessment questions: Always assess airway, breathing, circulation first; chest drain swinging/bubbling = classic exam scenario
Practice MCQs — Thoracic Surgery Nursing
1. A post-lobectomy patient's chest drain shows no swinging and no bubbling on day 2. Drainage has been 20 mL in the last 4 hours. What is the MOST likely explanation?
Answer: B — Absence of swinging with minimal drainage on post-op day 2 most likely indicates full lung re-expansion. Confirm with CXR before removing the drain. Tension pneumothorax (C) would cause haemodynamic instability and respiratory distress.
2. When inserting a chest drain, the needle should be placed at which position relative to the rib?
Answer: C — The needle is inserted over the SUPERIOR border of the rib below to avoid the neurovascular bundle (vein, artery, nerve — VAN) which runs in the subcostal groove on the inferior border of each rib.
3. A patient with a chest drain develops sudden respiratory distress, hypotension, absent breath sounds on the right, and tracheal deviation to the left. What is the priority nursing action?
Answer: B — This describes tension pneumothorax — a clinical emergency. Do NOT wait for CXR. Call for immediate medical review. Treatment is immediate needle decompression (2nd intercostal space, midclavicular line) followed by chest drain insertion. Clamping the drain (A) could worsen the situation.
4. Atrial fibrillation is MOST commonly observed at which time point following a major lung resection?
Answer: B — Post-thoracotomy AF classically peaks on post-operative day 2–4, driven by autonomic nervous system disruption, surgical inflammation, and fluid shifts. Continuous cardiac monitoring should extend at least to day 4–5.
5. A pleural fluid sample shows: protein 45 g/L (serum protein 60 g/L), LDH 350 IU/L (serum LDH 300 IU/L). According to Light's criteria, this effusion is:
Answer: B — Pleural protein/serum protein = 45/60 = 0.75 (>0.5) AND pleural LDH/serum LDH = 350/300 = 1.17 (>0.6). Both criteria are met = EXUDATE by Light's criteria. Further investigations needed for cause (cytology, culture, ADA).
6. Which spirometry finding is consistent with an OBSTRUCTIVE pattern?
Answer: B — Obstruction is defined by FEV₁/FVC ratio <70% (or <LLN). Option B shows ratio of 58% = obstructive. Option A shows reduced FEV₁ but normal ratio = restrictive pattern. Options C and D have normal ratios.
7. When performing therapeutic thoracocentesis, what is the maximum volume that should be drained in a single session to prevent re-expansion pulmonary oedema?
Answer: C — Maximum 1 litre (1000 mL) should be drained per session to prevent re-expansion pulmonary oedema, which occurs when a chronically collapsed lung expands rapidly. If more drainage is needed, the procedure should be paused or performed over multiple sessions.
8. A post-pneumonectomy patient on your ward develops sudden onset tachycardia, hypotension, and marked respiratory distress 24 hours post-operatively. The CXR shows the mediastinum has shifted AWAY from the operative side. What complication should you suspect?
Answer: C — Mediastinal shift AWAY from the operative side (rather than towards it) is abnormal and suggests cardiac herniation through a pericardial defect — a surgical emergency. This is distinct from normal post-pneumonectomy shift (which is towards the operative side as the space fills).
9. During post-talc pleurodesis nursing care, a patient develops fever of 38.5°C and tachycardia of 105 bpm at 3 hours post-procedure. The SpO₂ is 96% on room air and observations are otherwise stable. What is the MOST appropriate action?
Answer: B — Fever and tachycardia within the first 24 hours after talc pleurodesis are a well-recognised, self-limiting systemic inflammatory response (SIR) to talc. Antibiotics (A) are not indicated unless infection is confirmed. Symptomatic treatment (paracetamol, adequate fluid intake) is appropriate.
10. A patient's chest drain is bubbling CONTINUOUSLY, with SpO₂ 93%, and the patient is 48 hours post VATS lobectomy. What does this indicate and what is the priority action?
Answer: B — Continuous bubbling at 48 hours post-lobectomy indicates an ongoing alveolar-pleural fistula/air leak. This is not normal by day 2. NEVER clamp a bubbling drain (risk of tension pneumothorax). Notify the surgical team. Management may include suction, observation (most resolve), or re-intervention if persistent (>7 days).
Chest Drain Assessment Tool

Interactive Chest Drain Assessment Tool

Complete all fields to receive a structured drain status assessment, nursing actions, and criteria for escalating to the surgical team.

Nursing Actions

    Call Surgical Team If: